KLRA vs HOPE
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
KLRA · Kailera Therapeutics$12.97 ▲ 6.57%
HOPE · Hope Bancorp$13.18 ▲ 1.93%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- KLRA -50.1%
- HOPE +7.4%
Head to head
| Metric | KLRA | HOPE |
|---|---|---|
| Price | $12.97 | $13.18 |
| Change today | ▲ 6.57% | ▲ 1.93% |
| Market cap | $1.68B | $1.68B |
| Return, 3 months | -31.7% | -5.9% |
| Return, year to date | – | +24.2% |
| Return, 1 year | – | +30.1% |
| P/E (TTM) | – | 12.8 |
| P/B | 1.6 | 0.7 |
| P/E percentile vs own 5y | 81st | 57th |
| Dividend yield | – | 4.25% |
| Revenue growth (YoY, latest qtr) | – | +10.9% |
| Net profit growth (YoY) | -284.5% | +15.3% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 22.9% |
| Return on equity | -26.1% | 6.0% |
| Analyst target vs. price | +247.0% | +10.0% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 53 | 43 |
| 30-day volatility | 81.5% | 23.7% |
| Max drawdown, 1 year | -61.5% | -14.9% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- KLRA is the largest of the group by market value.
- HOPE has been the calmest stock over the last 30 days.